香港股市 將收市,收市時間:1 小時 49 分鐘

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
21.12-0.33 (-1.54%)
收市:04:00PM EDT
21.19 +0.07 (+0.33%)
收市後: 07:59PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價21.45
開市21.42
買盤0.00 x 1800
賣出價0.00 x 3100
今日波幅21.05 - 21.58
52 週波幅21.05 - 42.29
成交量9,427,698
平均成交量11,275,283
市值18.232B
Beta 值 (5 年,每月)0.69
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-3.84
業績公佈日2023年10月12日
遠期股息及收益率1.92 (8.79%)
除息日2023年8月18日
1 年預測目標價31.85
  • Kiplinger

    40% More Savings on Nearly 200 Medications at Walgreens with GoodRX

    If you’re struggling to afford prescriptions, GoodRx’s deal with Walgreens could help. Prices on nearly 200 medications will be cut by an average of 40%, and many can be bought for under $15 for a 30-day fill. If you're one of the many Americans struggling to afford prescription medication, GoodRx's deal with Walgreens could help you save the next time you're at the pharmacy. Prices on nearly 200 prescription medications will now be discounted by an average of 40%, and many prescriptions can now

  • InvestorPlace

    The Next Walgreens CEO? My Top 3 Picks to Replace Roz Brewer.

    Roz Brewer joined Walgreens Boots Alliance (NASDAQ:WBA) as its chief executive officer (CEO) with great fanfare in January 2021. “The Board conducted an extensive search to identify an exceptional leader who will build on WBA’s track record of success and take advantage of the many growth opportunities in many markets across the company. We are excited to have found that person in Roz,” said Stefano Pessina, the business’ largest shareholder. On Sept. 1, Brewer stepped down as CEO and board memb

  • Kiplinger

    Walgreens Expands Healthcare Reach With New Partnership

    The healthcare deal aims to help Walgreens grow its community-based primary care services. Walgreens is expanding further into value-based healthcare by partnering with Pearl Health, a startup technology firm and the retail pharmacy’s latest initiative to grow its community-based primary care services.Pearl is focused on primary care physicians transitioning away from fee-for-service compensation to value-based payments with the aim of reducing the total cost of care. The tech firm promotes Acco